Showing results (221-230 of 307) with videos related to
Sort By:
Pageof 31
Journal of Medicinal Chemistry|June 25, 2004
1,2,4-triazolo[4,3-a]quinoxalin-1-one moiety as an attractive scaffold to develop new potent and selective human A3 adenosine receptor antagonists: synthesis, pharmacological, and ligand-receptor modeling studiesVittoria Colotta, Daniela Catarzi, Flavia Varano, et al.Nature Chemical Biology|October 29, 2024
Selective bioorthogonal probe for N-glycan hybrid structuresMana Mohan Mukherjee, Devin Biesbrock, Lara K Abramowitz, et al.Bioorganic & Medicinal Chemistry Letters|October 12, 2011
Carbazole-containing arylcarboxamides as BACE1 inhibitorsSimone Bertini, Valentina Asso, Elisa Ghilardi, et al.European Journal of Medicinal Chemistry|December 7, 2015
Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptorLucia Squarcialupi, Daniela Catarzi, Flavia Varano, et al.Journal of Medicinal Chemistry|January 7, 2005
Combined target-based and ligand-based drug design approach as a tool to define a novel 3D-pharmacophore model of human A3 adenosine receptor antagonists: pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as a key studyStefano Moro, Paolo Braiuca, Francesca Deflorian, et al.Plos One|April 16, 2015
ALK kinase domain mutations in primary anaplastic large cell lymphoma: consequences on NPM-ALK activity and sensitivity to tyrosine kinase inhibitorsFederica Lovisa, Giorgio Cozza, Andrea Cristiani, et al.Inorganic Chemistry|May 13, 2008
Tuning the activity of Zn(II) complexes in DNA cleavage: clues for design of new efficient metallo-hydrolasesCarla Bazzicalupi, Andrea Bencini, Claudia Bonaccini, et al.Journal of Chemical Information and Modeling|February 1, 2020
Halogen Bonds in Ligand-Protein Systems: Molecular Orbital Theory for Drug DesignEnrico Margiotta, Stephanie C C van der Lubbe, Lucas de Azevedo Santos, et al.Journal of Medicinal Chemistry|September 30, 2025
Bitopic A3 Adenosine Receptor Molecular Probes: Positive Allosteric Modulation and Noncanonical ActivationSiva Hariprasad Kurma, Matteo Pavan, Tina C Wan, et al.Plos Pathogens|September 11, 2024
A comprehensive study of SARS-CoV-2 main protease (Mpro) inhibitor-resistant mutants selected in a VSV-based systemFrancesco Costacurta, Andrea Dodaro, David Bante, et al.Pageof 31